Our data, depicted in Figure 7 and Figure 8, show that up-regulation of MAGE-A3 in BM cell lines induced counter-regulation, indicating that MAGE-A3 is not a suitable target for targeted tumor therapy. Here, MAGEA3 is linked to neoplasm.